US EditionDanish Maker of Weightloss Drug Drops DEI Goals in U.S.
Summary by The European Conservative
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Danish Maker of Weightloss Drug Drops DEI Goals in U.S.
Novo Nordisk, the pharmaceutical company behind the successful and controversial weight loss drug Wegovy, announced on Wednesday that its diversity goal of having “at least 45 percent of each gender” in management will no longer apply to its U.S. activities, Danish state television reports.“If it’s illegal in the U.S. to measure, report, and reward people based on diversity, then of course we comply with those rules, but that doesn’t mean we aba…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
